Nephrology Visit - Lab and Medication Review
Date: 2025-12-10

Subjective:
No complaints. Home BP 126–134/74–82.

Objective:
BP 128/78, HR 70. Cr 1.5 mg/dL; Tac 6.8 ng/mL; Mg 2.0 mg/dL.
Lipid panel: LDL 132 mg/dL, HDL 42, TG 168.
A1c 6.9%.

Assessment/Plan:
- Stable graft function; tac at goal (6–8).
- Dyslipidemia: Start pravastatin 20 mg PO nightly (minimal CYP3A4 interaction with tacrolimus). Counsel on myalgia reporting.
- Diabetes management: Refer to Endocrinology for optimization; continue diet/exercise; monitor fasting glucose.
- Continue prophylaxis (valganciclovir, TMP-SMX) and current immunosuppression.
